Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma

Spleen size may serve as a promising prognostic marker in CAR T-cell therapy for RRMM patients, providing a simple and readily accessible tool for enhancing risk stratification. This finding could inform monitoring strategies and optimize healthcare resource management for these patients.

Authors

Institutions

Publication Details

Journal
Transplantation and Cellular Therapy
Published
2025-07-16
DOI
https://doi.org/10.1016/j.jtct.2025.07.003
Citations
1
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma

Hans‐Jonas Meyer, Klaus Hans Metzeler, Carmen Herling, Marco Herling et al.
1 citations
Transplantation and Cellular Therapy
CAR-T cell therapy research
1.05
article

Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma

Hans‐Jonas Meyer, Klaus Hans Metzeler, Carmen Herling, Marco Herling, Nora Grieb, Vladan Vučinić, Kristin Reiche, Song Yau Wang, Madlen Jentzsch, Simone Heyn, Timm Denecke, Patrick Born, Uwe Platzbecker, Thomas Neumuth, Heike Weidner, Maximilian Merz, David Fandrei, Maximilian Ferle, Luise Fischer, J. L. Ader, Georg‐Nikolaus Franke, Veronika Sotikova, Thomas C. Wiemers
article en
1 citations

Abstract

Spleen size may serve as a promising prognostic marker in CAR T-cell therapy for RRMM patients, providing a simple and readily accessible tool for enhancing risk stratification. This finding could inform monitoring strategies and optimize healthcare resource management for these patients.

Transplantation and Cellular TherapyVol. 31(10)
University Hospital Leipzig (DE), Fraunhofer Institute for Cell Therapy and Immunology (DE), Center for Systems Biology Dresden (DE), Technische Universität Dresden (DE), Leipzig University (DE)
Good health and well-being
Openalex Percentile: Top 20%
CAR-T cell therapy research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.